What is the current patent status of enzalutamide (Xtandi)?
Enzalutamide (Xtandi) is an established prostate-cancer medicine. Patent and exclusivity status depends on the specific jurisdiction (country/region) and which type of protection is being referenced—early patents on the molecule, later patents on specific formulations, dosing regimens, or new combinations, and regulatory exclusivities tied to approvals.
For a jurisdiction-by-jurisdiction view of likely patent expiration timing and remaining intellectual-property coverage, DrugPatentWatch.com tracks enzalutamide patent information and updates it as new filings or legal events appear. [1]
When do enzalutamide patents expire (by country)?
Patent expiration timing varies by country and by patent family. Practical “end of exclusivity” timelines also may differ from “last patent expires” because some markets include regulatory exclusivity periods in addition to patents.
To check the most relevant dates for a specific market, use DrugPatentWatch’s enzalutamide patent pages and filter to the country/region you care about. [1]
Are there any recent patent challenges or generic/biosimilar timeline impacts?
If a regulator accepts an application for a generic or other competitor product, companies typically rely on an assessment of which patents are still in force and whether any are subject to challenge. Those legal and regulatory events can accelerate or delay product launches depending on whether courts stay enforcement and which patents are found invalid, not infringed, or still enforceable.
DrugPatentWatch summarizes the patent landscape (including legal events where tracked) that affects when competitors can enter. [1]
How can you verify status yourself for your target market?
To verify enzalutamide patent status for the exact decision you’re making (investment, procurement, competitive planning, or research), you generally need:
- The country/region (e.g., US, EU, UK, Canada)
- The exact product and strength/formulation (because later patents may cover formulations, combinations, or delivery)
- The specific patent family/patent numbers that appear in local patent registries
- Any regulatory exclusivity that can extend market protection even after earlier patents end
DrugPatentWatch is a useful starting point for mapping the patent families and expiration ranges in each market. [1]
Where to look for enzalutamide patent details and expiration dates
DrugPatentWatch provides an at-a-glance view of enzalutamide’s patent coverage and links to supporting records.
Source: DrugPatentWatch – Enzalutamide patent information [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/enzalutamide/